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Best Practices for Evaluation and Treatment of Agitated Children and Adolescents (BETA) in the Emergency Department: Consensus Statement of the American Association for Emergency Psychiatry

Gerson R, Malas N, Feuer V, Silver GH, Prasad R, Mroczkowski MM

Erratum in

*West J Emerg Med*. 2019 July;20(4):688--689. There was a dosing error in [Table 2](#t1-wjem-20-688){ref-type="table"} regarding haloperidol dosing in pediatric agitation. The dose is listed as 0.55 mg/kg/dose and should be corrected to 0.05--0.1 mk/kg/dose.

Abstract

**Introduction:** Agitation in children and adolescents in the emergency department (ED) can be dangerous and distressing for patients, family and staff. We present consensus guidelines for management of agitation among pediatric patients in the ED, including non-pharmacologic methods and the use of immediate and as-needed medications.

**Methods:** Using the Delphi method of consensus, a workgroup comprised of 17 experts in emergency child and adolescent psychiatry and psychopharmacology from the the American Association for Emergency Psychiatry and the American Academy of Child and Adolescent Psychiatry Emergency Child Psychiatry Committee sought to create consensus guidelines for the management of acute agitation in children and adolescents in the ED.

**Results:** Consensus found that there should be a multimodal approach to managing agitation in the ED, and that etiology of agitation should drive choice of treatment. We describe general and specific recommendations for medication use.

**Conclusion:** These guidelines describing child and adolescent psychiatry expert consensus for the management of agitation in the ED may be of use to pediatricians and emergency physicians who are without immediate access to psychiatry consultation.
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###### 

Medication reference.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Medication                         Dose                                                             Peak effect                       Max daily dose                                            Notes/monitoring
  ---------------------------------- ---------------------------------------------------------------- --------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------------------------
  Diphenhydramine (antihistaminic)   PO/IM: 12.5--50mg\                                               PO: 2 hours                       Child: 50--100 mg\                                        Avoid in delirium.\
                                     1 mg/kg/dose                                                                                       Adolescent: 100--200 mg                                   Can be combined with haloperidol or chlorpromazine if concerns for EPS.\
                                                                                                                                                                                                  Can cause disinhibition or delirium in younger or DD youth.

  Lorazepam (benzodiazepine)         PO/IM/IV/NGT: 0.5 mg--2 mg\                                      IV: 10 minutes\                   Child: 4 mg\                                              Can cause disinhibition or delirium in younger or DD youth.\
                                     0.05 mg--0.1 mg/kg/dose                                          PO/IM: 1--2 hours                 Adolescent: 6--8 mg\                                      Can be given with haloperidol, chlorpromazine or risperidone.\
                                                                                                                                        Depending on weight/proir medication exposure             Do not give with olanzapine (especially IM due to risk of respiratory suppression.

  Clonidine (alpha2 agonist)         PO: 0.05 mg--0.1 mg                                              PO: 30--60 minutes                27--40.5 kg: 0.2 mg/day\                                  Monitor for hypotension and bradycardia.\
                                                                                                                                        40.5--45 kg: 0.3 mg/day\                                  Avaoid giving with BZD or atypicals due to hypotension risk.
                                                                                                                                        \>45 kg: 0.4mg/day                                        

  Chlorpromazine (antipsychotic)     PO/IM: 12.5--60 mg (IM should be half PO dose)\                  PO: 30--60 minutes\               Child \<5 years: 40mg/day\                                Monitor hypotension.\
                                     0.55 mg/kg/dose                                                  IM: 15 minutes                    Child \>5 years: 75mg/day                                 Monitor for QT prolongation.

  Haloperidol (antipsychotic)        PO/IM: 0.5 mg--5 mg (IM should be half a dose of PO)\            PO: 2 hours\                      15--40 kg: 6mg\                                           Monitor hypotension.\
                                     0.05--0.1 mg/kg/dose                                             IM: 20 minutes                    \>40 kg: 15 mg\                                           Consider EKG or cardiac monitoring for QT prolongation, especially for IV administration.\
                                                                                                                                        Depending on prior antipsychotic exposure                 Note EPS risk with MDD \> 3mg/day, with IV dosing having very high EPS risk.\
                                                                                                                                                                                                  Consider AIMS testing.

  Olanzapine (antipsychotic)         PO/ODT or IM: 2.5--10 mg (IM should be half or 1/4 dose of PO)   PO: 5 hours (range 1--8 hours)\   10--20 mg Depending on antipsychotic exposure             Do not give with or within 1 hour of any BZD given risk for respiratory suppresion
                                                                                                      IM: 15--45 minutes                                                                          

  Risperidone (antipsychotic)        PO/ODT: 0.25--1mg\                                               PO: 1 hour                        Child: 1--2 mg\                                           Can cause akathisia (restlessness/agitaion) in higher doses.
                                     0.005--0.01mg/kg/dose                                                                              Adolescent: 2--3 mg Depending on antipsychotic exposure   

  Quetiapine (antipsychotic)         PO: 25--50 mg\                                                   PO: 30 minutes-2 hours            \>10 years: 600 mg\                                       More sedating at lower doses\
                                     1--1.5 mg/kg/dose (or divided)                                                                     Depending on prior antipsychotic exposure                 Monitor hypotension.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*PO,* by mouth; *IM*, intramuscular; *IV*, intravenous; *NGT*, nasogastric tube; *mg*, milligram; *EPS*, extrapyramidal symptoms; *DD*, developmental disability; mg/kg, milligrams per kilogram; *BZD*, benzodiazepines; *EKG*, electrocardiogram; *AIMS*, Abnormal Involuntary Movement Scale; *MDD*, major depressive disorder; *ODT*, orally dissolving tablet.
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